| |
Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
BioReliance has significant experience in producing and testing gene therapy viral vectors.
|
The response of cytokines as a result of vector challenge may be measured by analysis on specific ELISA assays.
|  |
|
|
